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Abstract
In order to identify differences in functional activity, we
compared the reactivity of glioma vasculature and the
native cerebral vasculature to both dilate and constrict
in response to altered PaCO2. Gliomas were generated
by unilateral implantation of U87MGdEGFR human
glioma tumor cells into the striatum of adult female
athymic rats. Relative changes in total and micro-
vascular cerebral blood volume were determined by
steady state contrast agent–enhanced magnetic reso-
nance imaging for transitions from normocarbia to
hypercarbia and hypocarbia. Although hypercarbia
induced a significant increase in both total and micro-
vascular blood volume in normal brain and glioma,
reactivity of glioma vasculature was significantly
blunted in comparison to normal striatum; glioma total
CBV increased by 0.6F0.1% / mm Hg CO2 whereas
normal striatum increased by 1.5F0.2% / mm Hg CO2,
(P < .0001, group t-test). Reactivity of microvascular
blood volume was also significantly blunted. In con-
trast, hypocarbia decreased both total and microvas-
cular blood volumes more in glioma than in normal
striatum. These results indicate that cerebral blood
vessels derived by tumor-directed angiogenesis do
retain reactivity to CO2. Furthermore, reduced reactivity
of tumor vessels to a single physiological perturbation,
such as hypercarbia, should not be construed as a
generalized reduction of functional activity of the tumor
vascular bed.
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Introduction
In 1971, Folkman [1] proposed the necessity of angio-
genesis for sustained tumor growth. This hypothesis
sparked both academic as well as clinical interest in differ-
entiating the newly developed, tumor-directed vascular bed
from that of the tissue of origin, with the specific goal of
better detection and treatment of neoplasia. Although it has
been well established that tumor vasculature differs from the
preexisting vasculature in morphological characteristics includ-
ing vascular density and mean vessel radius [2–4], functional
properties of these new vessels have not been as extensively
investigated (for review, see Ref. [5]).
The ability of cerebral blood vessels to change diameter in
response to alterations in PaCO2 is a well-characterized prop-
erty of brain vasculature [6,7] by which small adjustments in
ventilation result in significant changes in both cerebral blood
flow (CBF) and cerebral blood volume (CBV) [8,9]. Recently,
several studies have exploited this property of cerebral hemo-
dynamics in order to assess the functional activity of blood
vessels within tumors noninvasively with magnetic resonance
imaging (MRI) [10–13]. In these reports, blood oxygenation
level–dependent (BOLD) signal was used to detect the func-
tional response of tumor vasculature to hypercarbia. BOLD
signal is proportional to regional deoxyhemoglobin content
[14,15]. In normal neural tissues with functionally active vas-
culature, BOLD signal intensity increases with hypercarbia
because the increased influx of oxygenated blood with no
significant change in oxygen utilization results in a decreased
deoxyhemoglobin content. Indeed, BOLD contrast has been
demonstrated to increase linearly in humans with arterial
carbon dioxide tension [16].
Reports using BOLD signal contrast to assess tumor
vascular reactivity to hypercarbia have produced conflicting
results. Abramovitch et al. [10] detected no significant change
in BOLD signal intensity in C6 gliomas with hypercarbia, but a
robust increase in signal intensity with hypercarbic hyperoxia.
Because hypercarbia appeared to have little effect on tumor
blood flow, they concluded that the tumor vascular bed
contained ‘‘immature’’ vessels, which lack the smooth muscle
elements necessary for vasodilation in response to an eleva-
tion in carbon dioxide. Using the same technique, Gross et al.
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[12] similarly reported little signal change with hypercarbia
in paraganglioma xenographs. Based on the lack of vascu-
lar reactivity, Neeman et al. [11] subsequently have pro-
posed that the differential increase in tumor BOLD signal
between induced hypercarbia and hypercarbic hyperoxia
could be used as a noninvasive index of vascular maturity
and angiogenesis. In contrast, however, Robinson et al. [13]
reported a 10% to 30% increase in BOLD image intensity in
GH3 prolactinomas with hypercarbia. In all of these studies,
however, tumors had been implanted subcutaneously into
the flank and the response of normal neural tissue was not
assessed in comparison.
Although BOLD contrast is proportional to changes in
local deoxyhemoglobin concentration, it is not possible to
quantify alterations in either CBF or CBV based on BOLD
signal intensity alone. This is largely due to the complex
relationship that exists within each tissue type between these
parameters and tissue oxygen extraction. Furthermore,
BOLD signal changes are proportional to baseline tissue
blood volume [17] that may be altered by angiogenesis. As
such, BOLD signal changes are, at best, imprecise meas-
ures of local hemodynamic effects and, consequently, direct
comparisons of physiological effects between tissues or
across hemodynamic perturbations are not possible.
With the availability of superparamagnetic contrast
agents that remain confined within the vascular space, it is
now possible to accurately quantify relative changes in blood
volume noninvasively by MRI with high spatial resolution.
Furthermore, it is possible to preferentially sensitize MRI
measurements of CBV toward the microvascular, or, alter-
natively, weight signal by total CBV by using steady state
contrast agent–enhanced imaging [18]. Magnetic suscepti-
bility contrast mechanisms predict that the change in relax-
ation rate observed with gradient echo (GE) images is
proportional to the volume of blood contained in all vessels,
whereas spin echo (SE) imaging is primarily sensitive to
vessels less than 30 Am. This technique of interrogation of
microvasculature was suggested by analytical simulations
and verified experimentally [2]. Therefore, adjustments in
both total andmicrovascular blood volumes can be assessed
dynamically by rapidly imaging tissues during physiological
perturbations.
Due to the inherent limitations of BOLD contrast as a
reporter of vascular activity and the variability of the results
from previous studies, the functional activity of tumor vascu-
lature remains an open question. To address this issue, we
quantified the difference in functional response to physiolog-
ical challenge between tumor vasculature and normal tissue.
We describe a direct quantitative measurement of the rela-
tive change in blood volume obtained simultaneously in both
vascular beds with steady state, contrast agent–enhanced
MRI. We assessed the functional response of the vascula-
tures to two challenges: 1) dilation in response to hyper-
carbia, and 2) constriction in response to hypocarbia. In
order to test the proposal that newly derived or ‘‘immature’’
vessels lack functional activity, we compared the reactivity of
blood volume between the entire vascular bed and the
microvascular compartment selectively. Because the imma-
ture nonfunctional vessels are smaller in size and predom-
inantly located in the microvascular compartment of the
tumor bed, a difference in functional reactivity between
compartments would indicate vessel size dependence in
response.
We selected an experimental tumor model that permitted
a direct comparison of functional activity of tumor vascula-
ture with that of normal brain, specifically implantation of a
human glioma–derived tumor cell line into normal brain. To
minimize the potential for graft-versus-host reaction that
could interfere with the functional behavior of tumor vascu-
lature, tumor cells were implanted in athymic host animals
that cannot mount such a response. The U87 cell line was
selected because it was derived from a human glioma and is
known to develop a highly vascular tumor similar to naturally
occurring neuroaxial neoplasms. Our results indicated that
although the reactivity of blood volume to carbon dioxide is




The U87MGdEGFR human glioblastoma cells were a
generous gift of Dr. H. -J. Su Huang (University of California
at San Diego). This cell line was established by retroviral
transfer of a mutant epidermal growth factor receptor (de 2-7
EGFR) into the U87MG human glioblastoma cell line,
enhancing its capacity to develop as a tumor in brains of
nude rats [19]. Cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum, 100 U/ml penicillin, 100 Ag/ml streptomycin,
and 50 Ag/ml G418 at 37jC in 5% CO2.
Tumor Implantation
Animal studies were performed in accordance with guide-
lines issued by the Massachusetts General Hospital Sub-
committee on Animal Care. Adult female nude rats (rnu/rnu;
NCI, Frederick, MD) were anesthesized with 12.5 mg of
ketamine and 2.5 mg of xylazine intraperitoneally. After
immobilization in a stereotactic apparatus, a linear skin
incision was made over the bregma and a 1-mm burr hole
was drilled in the skull approximately 1 mm anterior and 2
mm lateral to bregma on the right side. A total of 200,000
tumor cells in 2 Al were injected at a depth of 3.5 mm from the
dura using a 5-Al Hamilton syringe [19]. After awakening, rats
were returned to their cages until imaging.
Animal Imaging
Ten to 12 days after tumor implantation, rats were anes-
thesized with 1.5% halothane in oxygen for surgery; a
tracheostomy was placed and femoral arterial and venous
cannulae were inserted. Following surgery, rats were
mechanically ventilated with 0.7% halothane in a mixture of
air and oxygen using a 3-ml tidal volume and a rate of 40
breaths/min with inspiratory time:expiratory time ratio of 1:1.
After initiation of mechanical ventilation, rats were paralyzed
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with a 2-mg/kg bolus of pancuronium followed by continuous
intravenous infusion at 2 mg/kg per hour. To minimize motion
artifact, rats were placed into a custom-made plastic cradle
attached to a head frame machined from plastic (David Kopf
Instruments, Fremont, CA); heads were fixed with plastic
screws inserted into the ear canals and a bar inserted under
the front incisors. Rats were positioned prone in a 2-T, 11-cm
horizontal bore SISCO NMR scanner (Varian Associates,
Fremont, CA) with the head elevated approximately 1 cm
with respect to the torso. A custom-built surface transmit and
receive coil was applied firmly over the head. In order to
reduce magnetic susceptibility artifacts arising from the air–
tissue interface, rat heads were covered with gel toothpaste
before the positioning of the coil; the ear canals and orophar-
ynx were also filled with toothpaste. To maintain body
temperature, the rat torso was wrapped in two heating
blankets (Gaymar, Orchid Park, NY) that circulated water
at 40jC.
Imaging Protocols
Relative CBV was assessed by injection of a superpar-
amagnetic intravascular susceptibility contrast agent, mono-
crystalline iron oxide nanoparticle (MION), as described
previously [2,20]. Briefly, after obtaining stable physiological
condition and ventilation adjusted to attain normocarbia, a
set of 60 precontrast agent SE and GE single-shot echo
planar images (EPIs) was obtained through an interleaved
double echo protocol (TR/TEGE/TESE = 2500/22/60 milli-
seconds, FOV 2.5  2.5 cm, in-plane resolution: 780 Am)
with 11 slices of 1 mm thickness that covered the entire
tumor. A total dose of 3 mg/kg MION was injected intra-
venously and the sequence was repeated to obtain postcon-
trast agent images. In images obtained with a GE pulse
sequence, the change in relaxation rate resulting from injec-
tion of the intravascular contrast agent is proportional to total
blood volume. Images obtained with an SE pulse sequence
are preferentially sensitive to vessels less than 30 Am and,
therefore, the change in relaxation reflects the microvascular
blood volume compartment [18,21]. MION has a volume-
weighted hydrodynamic diameter of 17 nm, and remains
confined to the intravascular space in normal brain [22].
Previous studies have shown that there is no extravasation
of MION into the interstitial space of tumors during the
duration of these imaging experiments [2,23].
In order to determine the relative change in total and
microvascular blood volume during transitions to hypercarbia
and hypocarbia, an imaging sequence utilizing the same
parameters was used to record GE and SE images, respec-
tively, every 20 seconds. Following a baseline period of
approximately 6 minutes, in one set of rats (n = 8, Hyper-
carbia Group), hypercarbia was induced by addition of 5%
carbon dioxide to the inspired gas mixture and imaging
continued for approximately 20 minutes. In another set of
rats (n = 6, Hypocarbia Group), hypocarbia was induced by
increasing ventilation rate. The ratio of inspiratory to expir-
atory time was maintained at 1:1. Arterial blood samples
were obtained just prior to, and immediately after, imaging to
quantify pH, PaO2, and PaCO2; measurements were per-
formed with a Corning Blood Gas Analysis Machine (model
1304) on samples withdrawn from the femoral artery. Rat
core temperature and mean arterial blood pressure (MABP)
were monitored throughout the imaging session.
Image Data Analysis
Regions of tumor and contralateral striatumwere selected
for analysis by examination of postcontrast T2-weighted MR
images. Mean tumor diameter was determined by counting
the number of voxels in each slice representing the tumor and
converting voxels to millimeters. Regional CBV was calcu-
lated relative to the mean blood volume determined for the
contralateral normal striatum. The change in T2 relaxation
rate produced by the injection ofMIONwas used to determine
relative total and microvascular CBV from GE (DR2*) and SE
(DR2) images, respectively, by use of the formula: DR2 =
ln(Spre/Spost)/Te as previously described [2,20], where Spre
and Spost represent signal intensities preinjection and post-
injection of MION and Te is the echo time. Percent changes in
CBV in tumor and contralateral striatum during hypercarbia
and hypocarbia were calculated by comparisons of the aver-
age signal intensity at normocarbic baseline with the average
signal intensity obtained after the perturbation in the respira-
tory status by the formula: CBV(t)/CBV(0) = DR2(t)/DR2(0) as
previously described [20], where CBV(t) and DR2(t) are CBV
and DR2 at a specific time, respectively, and CBV(0) and
DR2(0) are the initial values for CBV and DR2, respectively.
Transition to a new stable signal intensity was determined
from review of the time course of signal intensity detected for
the region examined. Reactivities of total and microvascular
CBV were calculated for each rat by dividing the percentage
change in CBV by the change in PaCO2 in millimeters Hg.
Data are presented as meanFSEM; two-tailed t-tests were
used to quantify the significance of difference.
Histology and Analysis
Brains from six rats bearing U87 gliomas were fixed in situ
after imaging by intracardiac perfusion with 4% neutral
paraformaldehyde in phosphate-buffered saline (pH = 7),
removed, and then stored for 24 hours in perfusion fixative
followed by storage for 48 hours in 30% sucrose before
freezing. Frozen tissue sections, 10 Am thick, were cut on a
cryostat (Cryocut 2800 E; Leica, Deerfield, IL), thaw-
mounted onto glass microscope slides, and air-dried at room
temperature. Alternating tumor sections were stained with
NBT/BCIP (nitro blue tetrazolium/5-bromo-4-cloro-3-indolyl-
phosphate, toluidine salt) in order to identify vessels as
described; NBT/BCIP is enzymatically converted to a blue
precipitate by alkaline phosphatase present in blood vessel
endothelium [24]. Intervening sections were stained with
hematoxylin and eosin to aid in identification of anatomy.
Based on anatomical landmarks and tumor size, tissue
sections through tumors that corresponded to MR images
were selected for microscopic analysis. Four separate
regions for analysis were identified on each slide: contrala-
teral striatum and three subsections of tumor as edge,
middle, and center. Tumors were subdivided arbitrarily into
geometric areas such that the diameter of the center region
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was approximately the same as the widths of the two ring-like
regions surrounding the core for each tumor. Four separate
photo images were obtained for each region with a digitizing
microscope (Olympus BX60, Melville, NY) and processed
with the ImageProPlus software package (MediaCyber-
netics, Silver Spring, MD). The program identified vessels
based on the vascular stain; vessels appeared darker than
the counterstained tissue background. A semiautomated
method was used to select vessels in the field based on
setting a threshold of overall light intensity and breakdown of
color into red–green–blue components. Vessels were
counted in each field; vascular area was determined as the
fraction of total area contained within stained vessels. Vessel
radius was determined as the minimum distance in microns
from the center of each object to its edge. The results from
the four images were averaged for each of the individual
regions for all six animal brains.
Results
Tumor size and baseline physiological parameters were
similar between the Hypercarbia Group and the Hypocarbia
Group of rats. There was no significant difference in mean
tumor diameter between the two groups: 5.1F 0.5 mm in the
Hypercarbia Group and 5.0 F 0.2 mm in the Hypocarbia
Group. Furthermore, there were no significant differences in
normocarbic baseline values of pH, PaCO2, PaO2, and
MABP (Table 1). Hematocrit was slightly higher in rats
subjected to hypercarbia: 44% vs 37% (P < .01, pooled t-
test). After the addition of 5% carbon dioxide to the breathing
mixture, pH decreased and PaCO2 increased significantly
(P < .0001, paired t-test); with hyperventilation, pH increased
and PaCO2 decreased significantly (P < .003, paired t-test).
There was no significant change in MABP, PaO2, or hema-
tocrit as a result of either transition.
Both total and microvascular blood volumes contained
within U87 tumor vasculature were significantly elevated
relative to the contralateral striatum at the time of exper-
imentation. Figure 1 shows maps of relative total and micro-
vascular CBV generated from the change in R2* and R2,
respectively, after injection of MION contrast agent. At
normocarbic baseline, tumor total blood volume was ele-
vated in the Hypercarbia Group and the Hypocarbia Group
by factors of 3.5 F 0.3 and 4.1 F 0.2, respectively, relative
to the contralateral normal striatum (P < .0001, pooled t-test,
comparison between tumor and normal striatum). Similarly,
microvascular CBV was increased by factors of 2.2 F 0.2
and 2.9 F 0.2, respectively (P < .0001, pooled t-test, com-
parison between tumor and normal striatum). There was no
significant difference in elevation of either total or micro-
vascular tumor blood volume between the two treatment
groups. In both treatment groups, the elevation of total
blood volume within tumors was significantly greater than
the elevation of microvascular blood volume (P < .008,
pooled t-test).
Microscopic analysis of tissue sections stained for vas-
cular endothelium revealed that gliomas were significantly
more vascular than contralateral striatum (Figure 2), in good
agreement with the increased blood volumes determined by
MRI. Vessel density was increased significantly in gliomas
Table 1. Physiologic Data for U87- and GLI36-Bearing Rats During Perturbations of PaCO2.
Group Condition pH PaCO2 (mm Hg) PaO2 (mm Hg) MAP (mm Hg) Hematocrit (%)
Hypercarbia Baseline 7.36F0.02 36.3F1.3 163F6 126F5 44F1*
5% CO2 7.16F0.02
y 61.3F1.0y 163F6 124F4 46F1
Hypocarbia Baseline 7.41F0.03 35.7F0.7 173F16 111F9 37F2*
Hypervent. 7.53F0.05z 23.2F0.8z 205F7 112F6 34F2
Values are meanFSEM.
5% CO2: after addition of 5% carbon dioxide to breathing mixture; hypervent.: after increasing respiratory rate.
*Significant difference between groups at baseline: P < .01, pooled t-test.
yTransition induced significant change: P < .0001 paired t-test comparison between pretransition and posttransition.
zTransition induced significant change: P < .003 paired t-test comparison between pretransition and posttransition.
Figure 1. Representative relative CBV maps generated from DR2 and DR2* for SE (a) and GE (b) images, respectively, produced by intravenous administration of
MION (3.3 mg/kg iron) contrast agent. Each panel consists of five consecutive 1-mm-thick coronal slices rostral to caudal (left to right) through the tumor.
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relative to striatum; the number of vessels identified per high
power field increased from 86 F 15 in the striatum to 191 F
32 in the glioma (P < .02, pooled t-test tumor versus striatum,
n = 6). Similarly, vascular area was increased significantly in
gliomas; the percentage of area contained within blood
vessels per field increased from 2.2 F 0.2% in the striatum
to 5.3 F 1.2% in tumors (P < .003, pooled t-test). The
diameters of 3138 vessels in glioma and 2113 vessels in
normal striatum were determined from histological sections;
a histogram of the distribution of blood vessel sizes as a
percentage of the total population of vessels examined is
shown in Figure 3. Average vessel size was significantly
elevated in gliomas; mean blood vessel diameter increased
from 10.3 F 0.4 Am in the striatum to 16.8 F 1.3 Am in the
glioma (P < .004, pooled t-test). The vessel size distribution
demonstrated a higher proportion of large vessels contained
within gliomas; whereas only 20% of striatum vessels were
larger than 14 Am, 52% of tumor vessels fell into this range.
No necrotic areas were identified within the gliomas exam-
ined, and there were no significant differences detected in
either vascular area or mean vessel diameter between tumor
center, middle, or periphery.
A representative time course for the increase in total
CBV in tumor (closed circles) and contralateral normal
striatum (open circles) during transition from normocarbia
to hypercarbia is shown in Figure 4. There was no signifi-
cant drift with time in either GE or SE magnetic resonance
signal intensity in images obtained either at baseline or after
Figure 2. Photomicrographs of normal striatum (a) and U87 glioma (b) stained with NBT/BCIP to identify vascular endothelium; tissue counterstained with eosin.
Figure 3. Histograms of blood vessel diameters for normal striatum (left) and glioma (right). Data are presented as percentage of total population of vessels
examined in 1 lm size bins for 2113 vessels measured in normal striatum and 3138 vessels measured in gliomas from four tumor-bearing rats.
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transition to hypercarbia or hypocarbia. Because progres-
sive loss of MR signal would indicate leakage of the intra-
vascular contrast agent into the tumor interstitial space,
these results confirm the finding of Dennie et al. [2] that
MION does not pass into the interstitial space within tumors
within the time frame of these experiments.
Both hypercarbia and hypocarbia produced significant
changes in tumor total and microvascular CBV. Although
hypercarbia resulted in a significant increase in blood volume
in both tumor and normal striatum (P < .003, pretransition
versus posttransition comparison, paired t-test), the reactiv-
ity of tumor CBV to carbon dioxide was significantly blunted
as compared to the contralateral normal striatum (Table 2).
Total CBV increased by only 38% as much as the normal
striatum whereas microvascular CBV increased by 58% as
much as the normal striatum (P < .001, group t-test). In
contrast, whereas hyperventilation resulted in significant
hypocarbia (Table 1), blood volume decreased significantly
only in tumor vasculature with no significant change in either
total or microvascular CBV in normal striatum. In tumors, as
in normal striatum, there was no significant difference in
reactivity to carbon dioxide between total and microvascular
blood volume compartment either for transition to hyper-
carbia or hypocarbia.
Discussion
We interrogated the physiology of cerebral vasculature in
order to identify differences in functional activity between
tumor-derived vasculature and the native vasculature from
which it sprouted. Specifically, we quantified the reactivity of
both total and microvascular CBV to alterations in PaCO2.
Although vasodilation was blunted significantly in glioma
vascular bed as compared to normal striatum, tumor vessels
did constrict effectively in response to hypocarbia and to a
greater extent than the response of normal subcortex.
These results demonstrate several important features
regarding angiogenesis in experimentally derived tumors.
Firstly, although tumor vascularity may differ significantly
from the tissue of origin, blood vessels developed as a result
of tumor angiogenesis can exhibit functional activity typical of
the tissue from which the vessels sprouted. At normocarbia,
blood volume in the tumors examined here was significantly
elevated relative to surrounding brain and contralateral nor-
mal striatum. In addition, the elevation in the total blood
volume relative to normal brain was significantly larger than
the elevation in the microvascular compartment alone; total
blood volume was elevated by 51%more than microvascular
blood volume in gliomas. This indicates a disproportionate
increase in blood contained within larger vessels in the tumor
Figure 4. Time course generated for the change in total blood volume in a region of U87 tumor (closed circles) and contralateral normal striatum (open circles)
produced by transition to hypercarbia. A complete set of single-shot GE planar images covering eleven 1-mm-thick slices of brain were acquired every 20 seconds.
Relative CBV was calculated from signal intensity in regions of tumor and striatum on several slices as described in Materials and Methods section. After acquiring
a baseline set of images for approximately 6.5 minutes, 5% carbon dioxide was introduced into the breathing mixture and continued throughout the remainder of
image acquisition.







Tumor Striatum Tumor Striatum
Hypercarbia (n = 8) 0.6F0.2*,y 1.5F0.2* 0.6F0.1*,y 1.0F0.1*
Hypocarbia (n = 6) 1.0F0.4* 0.3F0.3 1.0F0.2* 0.1F0.5
Data presented as percent change CBV per millimeters mercury change in
PaCO2; values are meanFSEM.
*Transition induced significant change in blood volume; paired t-test
comparison between pretransition and posttransition blood volume.
ySignificant difference in reactivity to PaCO2 between tumor and striatum;
pooled t-test.
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vascular bed. This derangement of the tumor vascular bed
observed with imaging agreed well with the histological
analysis that confirmed the significantly more vascular
nature of these gliomas relative to normal striatum. Frac-
tional vascular area and vessel number in gliomas were
increased 2.4- and 2.2-fold, respectively, relative to normal
striatum. These values are comparable to the 2.5-fold
increase in microvascular blood volume determined by
MRI. Moreover, the distribution of tumor vessel diameters
revealed a pronounced shift in the population to larger
vessels; mean vessel diameter was increased by 63% in
tumors relative to striatum, confirming the disproportionate
increase in blood volume contained within larger vessels in
tumors. These results also agree well with previous reports
of elevated blood volumes in experimentally implanted glio-
mas and the dilated and tortuous blood vessels [4] that
characterize the three-dimensional vascular network [2,25].
Nonetheless, despite these distortions of normal vessel
anatomy and vascular architecture, we demonstrated an
appropriate functional response of the U87 glioma vascular
bed to both dilate and constrict with an acute change
in PaCO2.
Secondly, although the response of the tumor vascular
bed to hypercarbia was significantly blunted as compared to
normal tissue, this did not translate into a reduction in func-
tional ability to constrict in response to hypocarbia. Previous
reports have described little or no increase in tumor BOLD
signal intensity in experimentally implanted tumors chal-
lenged with hypercarbia [10–12]. Neeman et al. [11] pro-
posed that the differential response in BOLD contrast
between tumors subjected to hypercarbia alone and hyper-
carbic hyperoxia could be used as a noninvasive technique
to identify immature vessels that lack the functional activity to
dilate. Although we, as did they, observed impaired vaso-
dilation, our demonstration of highly effective vasoconstric-
tion within the tumor bed contradicts the notion that the
blunted response to hypercarbia is due to vessels within
the tumor that lack functional activity and, therefore, can be
classified as ‘‘immature.’’ Although these results do not rule
out the presence of a subpopulation of nonfunctional vessels
present in the tumor, they do point out that the gross
response of the vasculature to a single physiological chal-
lenge should be used with caution to comment on the
microanatomy of the vascular bed.
Further evidence arguing against a preponderance of
small nonfunctional blood vessels within the vascular bed
is the good agreement in reactivity between the total blood
volume and microvascular blood volume compartments.
Because relative CBV determined by GE imaging is sensitive
to all blood vessels, whereas SE imaging is primarily sensi-
tive to vessels less than approximately 30 Am, it is possible to
distinguish blood volume compartments with MRI [18]. If, as
has been proposed, the tumor vascular bed contained a
large population of ‘‘immature’’ blood vessels that lack
structural elements necessary for vasoreactivity, then the
microvascular compartment that contains predominantly
these smaller ‘‘immature’’ vessels would be expected to
exhibit less reactivity than the total blood volume compart-
ment that contains larger, more reactive vessels. Similar to
the behavior of normal brain, however, there was no signifi-
cant difference in reactivity between blood volume compart-
ments. Tumors derived from the C6 glioma cell line also have
a comparably disproportionate increase in blood volume
contained within large vessels [2] as demonstrated for the
U87 cell line reported here. Therefore, vessel size distribu-
tion cannot account entirely for the difference in results
reported here and those of Abramovitch et al. [10] and
Neeman et al. [11]. It is also important to note, however,
that previous studies have indicated only a minor contribution
of capillaries to adjustments in blood volume produced by
moderate hypercarbia [27–29].
As has been reported previously [2,20,30] and confirmed
here, we found no significant difference in reactivity to carbon
dioxide between total and microvascular blood volume com-
partments in normal brain. Therefore, the mechanical activity
responsible for alterations in vascular tone within tissues
affected both blood compartments equally. Because the
reactivity to carbon dioxide was also similar for both blood
volume compartments in gliomas, we conclude that this
physiological function was also preserved during angiogen-
esis. Despite the disproportionate increase in blood volume
contained within large vessels and distortions in normal
vessel anatomy, the mechanisms necessary for normal
maintenance of vascular resistance appear intact in these
tumors. Therefore, the tumor vascular bed appears to func-
tion more like normal brain than would be expected based on
the gross differences in vasculature.
There are two previous reports of tumor vasculature that
retain reactivity to changes in PaCO2. Robinson et al. [13]
attributed a 10–30% increase in T2*-weighted MRI signal
intensity during hypercarbia to be consistent with an increase
in tumor blood flow resulting from vasodilation in GH3
prolactinomas. Cenic et al. [31] reported significant
decreases in both blood flow and blood volume in VX2
tumors implanted intracranially in isoflurane-anesthesized
rabbits during hypocarbia. Interestingly, neither normal brain
nor tumor demonstrated any significant decrease in CBF or
CBV with hyperventilation when rabbits were anesthesized
with propofol. Although the specific characteristics of the C6
glioma cell line and the angiogenesis-derived tumor vascu-
lature may have been responsible for the lack of response to
hypercarbia in tumor xenografts implanted subcutaneously
in nude mouse flank reported by Abramovitch et al. [10]
and Neeman et al. [11], the limitations of BOLD imaging to
detect small changes in physiological parameters may also
have played a role. Alternatively, anesthetic conditions,
baseline blood volume, or location of implantation may have
contributed to the lack of response.
Several possible explanations could account for reduced
vasodilation but normal vasoconstriction in glioma vascula-
ture observed here. In their native state, tumor capacitance
vessels could be already near maximally dilated and have
little capacity to increase the diameter further in response to
an increase in CBF. Alternatively, local glioma CBF may be
near maximal with little capacity to increase. CBF has been
shown to be elevated in this tumor model [32]. Because the
336 Physiologic Function of Tumor Vasculature Packard et al.
Neoplasia . Vol. 5, No. 4, 2003
majority of tissue blood volume is located in the capillary and
venous compartments and is under relatively low pressure,
physical constraints of the immediate tumor environment
could influence venous compliance as well. The presence of
a space-occupying lesion within the closed confines of the
cranium can increase intracranial pressure—a condition
that impacts on cerebral hemodynamics. Elevation of tumor
intrinsic tissue pressure could exert a similar effect [33,34].
Finally, vascular reactivity could be a characteristic of indi-
vidual tumor cell lines. Using the same experimental design
described here, we quantified the vascular reactivity to
carbon dioxide for tumors derived from the human glioma
cell line GLI36. In that case, the increase in total and
microvascular blood volume induced by hypercarbia was
not different from the contralateral normal striatum (un-
published observation). Simultaneous determination of
changes in CBF and CBV during physiological challenge
could be helpful to distinguish between these possibilities.
The reactivity of CBV to hypercarbia for normal striatum
reported here (1.5 F 0.2% CBV/mm Hg PaCO2) compares
favorably to results obtainedpreviously byothers. Payenet al.
[35] reported a 1.7 F 0.3% increase in CBV per millimeters
mercury PaCO2 in the striatum for transition to hypercarbia
over a similar range of PaCO2 using GE planar MRI in
halothane/nitrous oxide–anesthesized normal rats. Simi-
larly, Mandeville et al. [20] reported a 1.3% increase and
Zaharchuk et al. [30] a 1.8% increase in CBV per millimeters
Hg PaCO2 in the whole brain of halothane-anesthesized rats
by GE MRI. For transition to hypocarbia, results are more
variable in quantifying the reduction in total CBV. Using
dynamic contrast-enhanced CT to measure CBV, Cenic
et al. [31,36] reported no significant difference in CBV during
transition to hypocarbia in propofol-anesthesized rabbits, but
a significant decrease of 1.1 F 0.5% CBV/mm Hg PaCO2
under isoflurane anesthesia. This difference in reactivity was
attributed to the vasoactive properties of the anesthetic to
effect baseline values of CBV. Similarly, Weeks et al. [37]
found that reactivity to carbon dioxide varied widely depend-
ing on anesthetic conditions; although halothane and pento-
barbital resulted in no significant change in CBV with
hypocarbia, CBV decreased by 1.4% mm Hg PaCO2 under
isoflurane anesthesia. In good agreement with these results,
we also found no significant decrease in CBV in normal brain
during hypocarbia under halothane anesthesia.
Among the functional properties that have been described
for normal cerebral circulation, MRI has been reported to
assess reactivity to carbon dioxide, autoregulation of blood
flow, blood flow metabolism coupling, and integrity of the
blood–brain barrier. Although penetration of the blood–brain
barrier by small-molecular-weight contrast agents is used
routinely to image neoplasms, the noninvasive determination
of disruption of other physiological properties of tumor vas-
culature has not become common in clinical practice. Recent
evidence has suggested, though, that neuroaxis neoplasms
may be graded for malignancy noninvasively based on
metabolic rate [38,39], blood volume, and blood flow
[40–42], and the kinetics of permeability to contrast agents
[43,44]. Further studies are necessary to determine the value
of vascular reactivity as a useful clinical marker either of
malignancy or of degree of neovascularity. The availability of
superparamagnetic intravascular susceptibility contrast
agents that do not penetrate a disrupted blood–brain barrier
will greatly facilitate the assessment of tumor vascular func-
tion in the clinical setting. Although it is unlikely that imaging
will replace surgical biopsies in the near future, imaging of the
functional properties of tumors may aid in the selection of
biopsy sites to improve the accuracy of diagnosis and selec-
tion of therapy. Finally, MRI assessment of vascular function
may help in elucidating the mechanism of angiogenesis and
prove useful in the development and evaluation of antiangio-
genic pharmaceuticals.
Summary
Although vasodilation in response to hypercarbia was sig-
nificantly blunted within U87 gliomas relative to normal brain,
vasoconstriction during hypocarbia was enhanced. This
pattern of reactivity was similar in response to the total as
well as the microvascular blood volume compartments.
Simple assessment of vascular response to hypercarbia with
indirect measures of hemodynamics may be inadequate to
determine functional activity and classify tumor-derived
blood vessels as immature.
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